Proto Script Pharmaceutical Corp. (PSCR) financial statements (2021 and earlier)

Company profile

Business Address 9830 6TH STREET, SUITE 103
RANCHO CUCAMONGA, CA 91730
State of Incorp. NV
Fiscal Year End December 31
SIC 733 - Mailing, Reproduction, Commercial Art And Photography, and Stenographic Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
5/31/2016
5/31/2015
5/31/2014
5/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments41211446
Cash and cash equivalents41211446
Receivables140    
Other current assets1   
Other undisclosed current assets    1
Total current assets:1451211447
Noncurrent Assets
Property, plant and equipment26    
Total noncurrent assets:26    
TOTAL ASSETS:1701211447
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:179712128
Accounts payable157  93
Accrued liabilities   45
Employee-related liabilities21    
Other undisclosed accounts payable and accrued liabilities 712  
Debt51    
Due to related parties178233  
Other liabilities167    
Other undisclosed current liabilities75    
Total current liabilities:4908945128
Noncurrent Liabilities
Total liabilities:4908945128
Stockholders' equity
Stockholders' equity attributable to parent, including:(320)(77)(44)140
Common stock3443333
Additional paid in capital6,953106106106106
Accumulated deficit(7,617)(186)(153)(108) 
Other undisclosed stockholders' equity attributable to parent    (70)
Total stockholders' equity:(320)(77)(44)140
TOTAL LIABILITIES AND EQUITY:1701211447

Income statement (P&L) ($ in thousands)

12/31/2016
5/31/2016
5/31/2015
5/31/2014
5/31/2013
Revenues
(Revenue, Net)
789    
Cost of revenue
(Cost of Goods and Services Sold)
(224)(9)(5)  
Gross profit:564(9)(5)  
Operating expenses(863)(33)(45)(38)(46)
Other undisclosed operating income    14
Operating loss:(298)(42)(50)(38)(32)
Nonoperating expense(6,885)    
Interest and debt expense(6,885)    
Net loss:(14,067)(42)(50)(38)(32)
Other undisclosed net income attributable to parent6,88595  
Net loss available to common stockholders, diluted:(7,183)(33)(45)(38)(32)

Comprehensive Income ($ in thousands)

12/31/2016
5/31/2016
5/31/2015
5/31/2014
5/31/2013
Net loss:(14,067)(42)(50)(38)(32)
Comprehensive loss, net of tax, attributable to parent:(14,067)(42)(50)(38)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: